Roche Diagnostics cobas™ Liat Influenza A/B + RSV Assay

Automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A and B virus and RSV RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.

• Testing accuracy with RT-PCR technology
• Definitive results with no need for interpretation or confirmation
• Fast, easy operation
• Three easy steps
• Results in 20 minutes

Accuracy

Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4%

Certifications/Compliance

None

Content And Storage

36°F to 46°F

Control Sets

Controls purchases separately (FCAT# 23312203)

CPT Code

87631

CE Marker

No

Clia Complexity

Waived

Detectable Analytes

Influenza A and B, Respiratory Syncytial Virus (RSV) RNA

Format

Case (Kit)

Sample Type

Nasopharyngeal

Sensitivity

Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4%

Type

Nucleic Acid RT-PCR Influenza A, Influenza B, RSV

Packaging Type

Case (kit)

Quantity

20 Tests/Cs. (Kit)

Specificity

Negative Agreement: Influenza A 96.5%; Influenza B 99.4%; RSV 98.4%

Test Time

20 min.